Search results
Found 17940 matches for
The University of Oxford and Sound Pharmaceuticals completed this new Phase 2a study testing SPI-1005, an investigational drug that contains ebselen, as a new treatment for bipolar disorder.
EXTEND Newsletter: Issue 1, January 2023
Issue #1 of the quarterly newsletter for the EXTEND Study
According to EXTEND-InG
Members of the EXTEND Involvement Group on why the EXTEND project is important and why they've got involved.